Charles L. Raison, MD

BAYSHORE ELEMENTARY

Articles

Inflammation and Treatment Resistance in Major Depression: The Perfect Storm

September 12, 2013

New findings provide powerful evidence that inhibition of inflammation or its downstream effects on mood may open up a host of new approaches to treatment for depression, especially for patients with treatment-resistant depression.

From Chaos to Consilience: Part III

August 08, 2009

What the New Mind-Body Science Tells Us About the Pathophysiology of Major Depression-Focus on Treatment

And the Orchestra Played On: Activation of Distress Pathways-A Common Feature of Mood, Anxiety, Sleep, and Pain Disorders?

July 08, 2009

As we begin this brief review of the neurobiology of major depressive disorder (MDD), we face these fundamental questions

From Chaos to Consilience: Part IIWhat the New Mind-Body Science Tells Us About the Pathophysiology of Major Depression

July 07, 2009

We would suggest that psychiatry has spent so many years taking its diagnostic categories as God-given that it has become inured to the fact that these categories tell us very little about the etiology and fundamental nature of the conditions they purport to encompass.

From Chaos to Consilience: Using the New Mind-Body Science to Improve the Diagnosis and Treatment of Major Depression

May 08, 2009

Lecturing around the country has left us with the powerful impression that both psychiatrists and primary care physicians are hungry for new ways to think about and manage depression and the myriad symptoms and syndromes with which it is associated-including attention deficit disorder, insomnia, chronic pain conditions, substance abuse, and various states of disabling anxiety.

From Chaos to Consilience

April 24, 2009

Lecturing around the country has left us with the powerful impression that both psychiatrists and primary care physicians are hungry for new ways to think about and treat depression and the myriad symptoms and syndromes with which it is associated-including attention deficit disorder, insomnia, chronic pain conditions, substance abuse, and various states of disabling anxiety. Primary care physicians also seem especially excited to learn that depression is not just a psychiatric illness but a behavioral manifestation of underlying pathophysiological processes that promote most of the other conditions they struggle to treat-including cardiovascular disease, diabetes, cancer, and dementia.1,2

Recognizing and Treating Interferon-α–Induced Neuropsychiatric Symptoms

August 02, 2008

The fact that treatment with interferon (IFN)-α has become the world’s foremost human model for studying how the innate immune system promotes depression points to a disturbing clinical truth: patients who elect to receive (IFN)-α therapy for any of the several disease states to which it is applied face a high likelihood of experiencing a multitude of psychiatric symptoms severe enough to affect their social and occupational functioning and overall well-being.1

Buddhists Meet Mind Scientists in Conference on Meditation and Depression

March 01, 2008

On October 20, 2007, leading researchers in the fields of mood disorders and meditation discussed the promise-and limitations-of meditation for the prevention and treatment of major depression. Participating in a day-long symposium titled "Mindfulness, Compassion, and the Treatment of Depression" was His Holiness the Dalai Lama.